Drugplain

REBINYN

coagulation factor IX recombinant, GlycoPEGylated · KIT · Novo Nordisk

No Recall History
Plain English

REBINYN is a kit containing coagulation factor ix recombinant, glycopegylated. Manufactured by Novo Nordisk.

Key Facts

Brand Name
REBINYN
Generic Name
coagulation factor IX recombinant, GlycoPEGylated
NDC Code (Product)
0169-7902
Manufacturer
Novo Nordisk
Dosage Form
KIT
Marketing Status
Application #
BLA125611
Marketing Start
12/01/2017

Recall History

No Recall History

Frequently Asked Questions

What is REBINYN used for?

REBINYN contains coagulation factor IX recombinant, GlycoPEGylated. It is a kit taken as directed. Consult your doctor for specific uses.

Is REBINYN a controlled substance?

REBINYN is not classified as a controlled substance by the DEA.

What is the generic name for REBINYN?

The generic name for REBINYN is coagulation factor IX recombinant, GlycoPEGylated. There are no other listed brand versions of coagulation factor IX recombinant, GlycoPEGylated.

What is the NDC code for REBINYN ?

The NDC (National Drug Code) for REBINYN is 0169-7902, listed by Novo Nordisk.

Product NDC

0169-7902

Package NDC

0169-7902-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)